Home / Tag Archives: GLP-1 prescribing

Tag Archives: GLP-1 prescribing

Fragmented Care in the GLP-1 Era: What Happens When Multiple Providers Prescribe the Same Therapy?

Patient navigating GLP-1 therapy while multiple healthcare providers coordinate diabetes and obesity treatment across telehealth and clinical settings.

A patient starts semaglutide through a telehealth platform, receives nutrition advice from a wellness clinic, and later visits a primary care physician for worsening gastrointestinal symptoms. None of the providers can see the full treatment picture. Situations like this are becoming increasingly common as GLP-1 medications move across multiple corners …

Read More »

Are GLP-1 Drugs Being Prescribed Too Early? Rethinking Risk Thresholds in Diabetes Care

Balance scale comparing healthy lifestyle habits and GLP-1 diabetes medications in a modern medical office setting

A patient loses 30 pounds, lowers their A1C, and improves their blood pressure within months of starting a GLP-1 medication. Stories like these are hard to ignore, and they have helped fuel growing enthusiasm around drugs like Ozempic, Wegovy, and Mounjaro. Yet as prescriptions continue to expand beyond high-risk diabetes …

Read More »